headquartered in cupertino, california, aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advanced biorefineries. founded in 2006, aemetis owns and operates a 60 million gallon per year ethanol production facility in california’s central valley, near modesto. aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the east coast of india producing high quality distilled biodiesel and refined glycerin for customers in india, the us and europe. aemetis operates a research and development laboratory at the maryland biotech center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. for additional information about aemetis, please visit
Company profile
Ticker
AMTX
Exchange
Website
CEO
Eric McAfee
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AE Biofuels, Inc., AE BIOFUELS, INC., MARWICH II LTD
SEC CIK
Corporate docs
Subsidiaries
Aemetis Advanced Biorefinery Keyes, Inc. • Aemetis Advanced Fuels, Inc. • Aemetis Advanced Products Keyes, Inc. • Aemetis Health Products, Inc. • Aemetis Properties Riverbank, Inc. • Aemetis Riverbank, Inc. • Aemetis Advanced Products Riverbank, Inc. • Aemetis Americas, Inc. • AE Biofuels, Inc. • Aemetis Biofuels, Inc. ...
IRS number
261407544
AMTX stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
29 Mar 24
10-K
2023 FY
Annual report
29 Mar 24
NT 10-K
Notice of late annual filing
15 Mar 24
8-K
Aemetis Reports 2023 Fourth Quarter and Year-End Results
7 Mar 24
8-K
Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028
20 Feb 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Dec 23
424B3
Prospectus supplement
13 Dec 23
EFFECT
Notice of effectiveness
13 Dec 23
Transcripts
AMTX
Earnings call transcript
2023 Q4
7 Mar 24
AMTX
Earnings call transcript
2023 Q3
9 Nov 23
AMTX
Earnings call transcript
2023 Q2
3 Aug 23
AMTX
Earnings call transcript
2023 Q1
4 May 23
AMTX
Earnings call transcript
2022 Q4
9 Mar 23
AMTX
Earnings call transcript
2022 Q3
6 Nov 22
AMTX
Earnings call transcript
2022 Q2
6 Aug 22
AMTX
Earnings call transcript
2022 Q1
13 May 22
AMTX
Earnings call transcript
2021 Q4
11 Mar 22
AMTX
Earnings call transcript
2021 Q3
12 Nov 21
Latest ownership filings
SC 13G/A
Encompass Capital Advisors LLC
14 Feb 24
SC 13G/A
ALLIANCEBERNSTEIN L.P.
14 Feb 24
SC 13G/A
Grantham, Mayo, Van Otterloo & Co. LLC
13 Feb 24
4
JAMES MICHAEL ROCKETT
22 Jan 24
4
ANDREW B FOSTER
22 Jan 24
4
JOHN R BLOCK
22 Jan 24
4
Naomi Louise Boness
22 Jan 24
4
Todd Waltz
22 Jan 24
4
Sanjeev Gupta
22 Jan 24
4
Timothy Alan Simon
22 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm |
Cash burn (monthly) | (no burn) | (no burn) | 8.20 mm | 8.07 mm | 2.05 mm | 2.22 mm |
Cash used (since last report) | n/a | n/a | 54.72 mm | 53.86 mm | 13.71 mm | 14.85 mm |
Cash remaining | n/a | n/a | -47.06 mm | -46.19 mm | -6.04 mm | -7.18 mm |
Runway (months of cash) | n/a | n/a | -5.7 | -5.7 | -2.9 | -3.2 |
Institutional ownership, Q3 2023
24.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 72 |
Opened positions | 17 |
Closed positions | 20 |
Increased positions | 19 |
Reduced positions | 17 |
13F shares | Current |
---|---|
Total value | 42.92 bn |
Total shares | 10.57 mm |
Total puts | 505.90 k |
Total calls | 576.80 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Grantham, Mayo, Van Otterloo & Co. | 1.97 mm | $8.18 bn |
Encompass Capital Advisors | 1.75 mm | $7.26 bn |
Vanguard | 1.63 mm | $6.76 bn |
SF Stifel Financial | 691.45 k | $2.87 bn |
Susquehanna International | 516.79 k | $2.14 bn |
BLK Blackrock | 488.81 k | $2.03 bn |
Millennium Management | 380.87 k | $1.58 bn |
Geode Capital Management | 330.20 k | $1.37 bn |
National Bank of Canada | 298.60 k | $1.29 bn |
Group One Trading | 234.82 k | $974.50 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jan 24 | Mcafee Eric A | Common Stock | Grant | Acquire A | No | No | 0 | 300,000 | 0.00 | 3,317,136 |
18 Jan 24 | Barton Francis P | Common Stock | Grant | Acquire A | No | No | 0 | 17,000 | 0.00 | 196,893 |
18 Jan 24 | Lydia I Beebe | Common Stock | Grant | Acquire A | No | No | 0 | 13,500 | 0.00 | 170,338 |
18 Jan 24 | Timothy Alan Simon | Common Stock | Grant | Acquire A | No | No | 0 | 11,000 | 0.00 | 43,441 |
18 Jan 24 | Gupta Sanjeev | Option Common stock and Series B Preferred | Grant | Acquire A | No | No | 3.09 | 200,000 | 618.00 k | 1,005,000 |
News
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
22 Mar 24
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
21 Mar 24
HC Wainwright & Co. Reiterates Buy on Aemetis, Maintains $28 Price Target
8 Mar 24
Earnings Scheduled For March 7, 2024
7 Mar 24
Aemetis's Earnings Outlook
6 Mar 24
Press releases
Aemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency Projects
9 Apr 24
4 Stocks That Will Benefit From The Green Energy Revolution (VVPR, AMTX, MAXN, SMR)
4 Apr 24
4 Stocks That Will Benefit From The Green Energy Revolution
4 Apr 24
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
21 Mar 24
Aemetis Reports 2023 Fourth Quarter and Year-End Results
7 Mar 24